Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMothercare Regulatory News (MTC)

Share Price Information for Mothercare (MTC)

Share Price is delayed by 15 minutes
Get Live Data
1.00    0.00 (0.00%)
Bid:
0.755
Ask:
1.00
Spread: 0.245 (32.45%)
Market Cap: £5.64m
MTC Live PriceLast checked at - London Stock Exchange

Intraday Mothercare Share Chart

Pre-close trading update

13 Apr 2026 07:00

Pre-close trading update
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Mothercare plc

Pre-close trading update

Mothercare plc ("Mothercare" or "the Company"), the leading specialist global brand for parents and young children, today issues a pre-close trading update for the 52 week period to 28 March 2026 (“FY26”). Comparatives are based on the 52 week period to 29 March 2025. This update is based upon draft figures pending finalisation of the year end audit.

• Unaudited worldwide retail sales by franchise partners of £180 million for the year, representing a decline of 22% on last year (19% down at constant currency)

• Adjusted EBITDA for FY26 at approximately £1.25 million

• Net borrowings of £5.7 million at the year end (March 2025: £3.7 million).

• Pension scheme deficit remains at £35 million as at 31 December 2025, which is the latest available estimate (March 2025: £35 million) on a technical provisions basis.

The performance reflects variously the end of our exclusive distribution relationship with Boots at the end of 2025, foreign exchange rate impacts and the longstanding uncertainty in our Middle Eastern markets, including the more recent impact of the Iran war in the last month of the period.

EBITDA before adjusting items for FY26, is now expected to be approximately £1.25 million, compared to the £3.5 million adjusted EBITDA for the period to March 2025. We estimate that the impact of the war in the Middle East, in the last month of the period under review, to be approximately £0.1m.

The underlying strength of the business is demonstrated by the fact that excluding the Middle East and the UK, where we continue to believe that there remains a greater opportunity for the brand and a new partner in the UK, on a like for like basis our total retail sales were positive for the full year to March 2026.

There has been no material change to the Group’s financial position since the announcement made on 20 February 2026, setting out the successful and timely refinancing of the Group’s debt facilities and the deferral of contributions to the Group’s pension schemes.

Clive Whiley, Chairman of Mothercare, commented:

“Our results for last year reflect the impact of the continuing uncertainty on our franchise partners’ operations in the Middle East, where any longer-term impact upon supply chains remains unclear at this stage, and the underlying profitability and cash generation of our asset-light franchise system.

The full refinancing of our debt facilities in February 2026 has bought additional time to engineer a more comprehensive solution to harvest the value of the brand IP and the significant operational gearing available to an expanded business. In these circumstances the recent financial performance has been usefully resilient as we look to FY27, whilst acknowledging the impact of the continuing disruption from events in the Middle East.

Given the external factors influencing some of the Company’s key operating markets, our immediate priority remains to support our franchise partners, ultimately for the benefit of our own underlying business, where the strength of the Mothercare brand endures. We remain in discussions with several parties to restore critical mass, a process greatly assisted by the recent alignment of the first-charge debt instrument with our equity.

I would like to thank all of our colleagues and stakeholders for their support and efforts in difficult circumstances, and the board remains determined to optimise the brand IP for the benefit of all stakeholders.“

Investor and analyst enquiries to:

Mothercare plc  Email: investorrelations@mothercare.comClive Whiley, ChairmanAndrew Cook, Chief Financial Officer Deutsche Numis Tel: 020 7260 1000(NOMAD & Joint Corporate Broker)  Luke BordewichAneesh Oza

Cavendish Capital Markets Limited  Tel: 020 7220 0500(Joint Corporate Broker) 

Matt Goode

This announcement contains information that is inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (the Market Abuse Regulation ("MAR")). Upon the publication of this announcement, such information will no longer constitute inside information. Andrew Cook, the Company's CFO, is the person responsible for making the notification for the purposes of Article 17 of MAR.

Date   Source Headline
30th Aug 201912:14 pmGNWHolding(s) in Company
1st Aug 20198:16 amGNWTotal voting rights
26th Jul 201912:53 pmRNSResult of AGM
26th Jul 20197:00 amRNSFY20 Q1 Trading Update
26th Jun 20199:14 amGNWBlock listing Interim Review
25th Jun 20199:15 amGNWAnnual Financial Report and Notice of Annual General Meeting
10th Jun 201910:57 amGNWDirector Declaration
24th May 20197:00 amRNSFinal Results
23rd May 20197:00 amGNWPreliminary Results update
10th May 20199:09 amGNWHolding(s) in Company
8th May 20194:36 pmRNSPrice Monitoring Extension
7th May 20194:35 pmRNSPrice Monitoring Extension
4th Apr 20197:00 amRNSFY19 Q4 Trading Update
1st Apr 20197:18 amGNWDirector/PDMR Shareholding
29th Mar 20193:24 pmGNWDirector/PDMR Shareholding
29th Mar 201911:34 amGNWResult of Meeting
22nd Mar 20191:27 pmRNSChange of Auditor
22nd Mar 201912:35 pmGNWFurther re disposal of ELC
15th Mar 201910:39 amGNWHolding(s) in Company
15th Mar 20199:22 amGNWDirector/PDMR Shareholding
13th Mar 20193:58 pmGNWHolding(s) in Company
13th Mar 20197:00 amGNWNotice of GM
12th Mar 20197:40 amRNSUpdate on transformation and disposal of ELC
18th Feb 20194:38 pmRNSHolding(s) in Company
23rd Jan 201912:53 pmGNWHolding(s) in Company
9th Jan 20197:00 amRNSTrading Update
7th Jan 201911:31 amGNWDirector/PDMR Shareholding
21st Dec 20184:00 pmGNWBlock listing Interim Review
22nd Nov 20187:00 amRNSHalf-year Report
15th Nov 201812:44 pmGNWHolding(s) in Company
9th Nov 20183:14 pmGNWHolding(s) in Company
31st Oct 20182:52 pmGNWHolding(s) in Company
25th Oct 20189:09 amGNWDirectorate change
14th Sep 20189:17 amGNWDirectorate change
22nd Aug 20188:00 amGNWDirector/PDMR Shareholding
1st Aug 20183:47 pmGNWTotal voting rights
27th Jul 20188:13 amGNWDirector/PDMR Shareholding
26th Jul 201810:38 amRNSResult of Meeting
26th Jul 20187:00 amRNSResult of Placing and Open Offer
19th Jul 20182:16 pmGNWAGM results
9th Jul 20183:17 pmRNSPublication and posting of Prospectus
9th Jul 20188:31 amRNSEquity issue timetable
9th Jul 20187:00 amRNSEquity issue and restructuring
14th Jun 20189:02 amGNWAnnual Report, Notices of Meetings and Directorate changes
4th Jun 201812:38 pmRNSUpdate re CVA Meetings
1st Jun 20182:15 pmRNSCVA Proposals: Results of Creditors' Meetings
21st May 201811:34 amGNWDirector/PDMR shareholdings
18th May 20184:01 pmGNWDirectorate change
18th May 20189:11 amRNSFurther re directorate
17th May 20181:09 pmRNSFY2017/18 Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.